Portrait-style image embedded in the Shanghai Children's Medical Center article announcing Shen Shuhong's national physician honor.

Shen Shuhong

沈树红

Chief Physician, Professor, Doctoral Supervisor, and Director of Hematology & Oncology

Pediatric leukemia, especially acute lymphoblastic leukemia, molecularly guided treatment of refractory leukemia, and broader pediatric hematologic malignancies(儿童白血病,重点为急性淋巴细胞白血病,以及难治性白血病的分子机制分析与靶向治疗,并涵盖儿童血液系统恶性肿瘤)

200 National leukemia consultation cases / year

(scmc.com.cn)

Leadership & Positions

  • Director, Department of Hematology & Oncology, Shanghai Children's Medical Center
  • Leader of the CCCG pediatric acute lymphoblastic leukemia collaborative group
Request Consultation with Shuhong

Notable Publications

Sequence-dependent splicing dysregulation drives therapy resistance in pediatric AML.

Cell Reports Medicine (2026) — co-author

PubMed/DOI

The comprehensive landscape of TTMV::RARA fusiondriven acute myeloid leukemia: from viral integration mechanisms to clinical outcomes.

Haematologica (2026) — co-author

PubMed/DOI

Blinatumomab demonstrates MRD eradication in MRD-positive/chemotherapy-delayed pediatric B-ALL and high response in relapsed/refractory cases: a multicenter cohort study.

Frontiers in Immunology (2025) — co-author

PubMed/DOI

Pioneering Contributions

  • Led the globally largest pediatric acute lymphoblastic leukemia collaborative group according to the hospital's official 2023 profile of his work.
  • Helped raise pediatric ALL survival to internationally advanced levels, reported by the hospital as 91% in the collaborative program and 93% 5-year survival on the department page.
  • Pushed molecularly guided targeted treatment strategies for refractory pediatric leukemia and supported a national pediatric leukemia referral and consultation network.

Sources — Shen Shuhong

Request a case review with Shen Shuhong

Our team will coordinate your consultation.

Request Case Review